(Q40200929)

English

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels

scientific article published on December 2006

Statements

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels (English)
Barbara A Helfrich
David Raben
Dan Gustafson
Daniel C Chan
Lynne Bemis
Chris Coldren
Anna Barón
Chan Zeng
Wilbur A Franklin
Adi Gazdar
John Minna
Paul A Bunn
1 December 2006
7117-7125

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit